![]() |
市场调查报告书
商品编码
1829256
2025年全球泌尿系统医疗雷射市场报告Urology Medical Lasers Global Market Report 2025 |
近年来,泌尿系统医用雷射市场规模稳定成长,从2024年的10.3亿美元增加到2025年的10.6亿美元,复合年增长率为3.2%。预测期内的成长可归因于科技的快速进步、医疗支出的不断增长、老年人口的快速成长、公共医疗保险改革以及新兴市场的强劲经济成长。
预计未来几年泌尿系统医用雷射市场将强劲成长,到2029年将达到13.3亿美元,年复合成长率(CAGR)为5.9%。预测期内的成长将受到併购活动增加、研发和创新力度加大以及政府倡议的推动。预测期内的主要趋势包括新技术的涌现、巨量资料和人工智慧的应用、针对良性前列腺增生的创新雷射治疗以及光纤在雷射技术中的应用。
泌尿系统医用雷射是泌尿系统的专用仪器,用于针对泌尿道、膀胱、肾臟、前列腺和其他相关器官进行一系列微创手术和治疗。这些雷射透过发射集中的光束来精确切割、汽化或碎裂组织。使用这些雷射器的好处是减少出血、加快恢復速度,并最大程度地减少对周围组织的损伤。
泌尿系统医疗雷射市场由各种类型的雷射组成,包括钬雷射系统、二极体雷射系统和铥雷射系统。钬雷射系统用于透过雷射手术去除结石,尤其是位于膀胱、肾臟、输尿管和尿道的结石。这些雷射的应用范围也扩展到治疗良性前列腺增生 (BPH)、尿道结石和非肌肉层浸润性膀胱癌 (NMIBC)。泌尿系统医疗雷射的主要终端使用者包括医院、诊所和其他医疗机构。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供泌尿系统医疗激光器市场统计数据,例如全球市场规模、区域份额、竞争对手的泌尿系统医疗激光器市场份额、详细的泌尿系统医疗激光器细分泌尿系统、市场趋势和商机,以及您在泌尿系统医疗激光器行业取得成功所需的数据。本泌尿系统医疗雷射器市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
我们预测未来五年市场将成长5.9%,较先前预测略有下降0.4%。下降的主要原因是美国与其他国家之间关税的影响。这可能会直接影响美国,导致来自俄罗斯和新加坡等主要地区的铥雷射晶体和光纤传输系统供应链中断,这可能导致前列腺治疗技术供应减少。此外,由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响也将更加广泛地显现。
泌尿系统疾病的发生率不断上升是推动泌尿系统医疗雷射市场需求的关键因素。包括膀胱癌和前列腺疾病在内的泌尿系统病例的增加,推动了对微创手术及相关设备的需求。根据美国癌症研究所的统计数据,膀胱癌是男性第六常见癌症,女性第十七大常见癌症。泌尿系统疾病和病症的激增刺激了泌尿系统手术的需求,并支持了泌尿系统医疗雷射市场的成长。
泌尿系统疾病的持续上升预计将进一步推动泌尿系统医疗雷射市场的发展。泌尿器官系统疾病涵盖影响男性和女性生殖和泌尿系统的各种问题。常见的泌尿系统疾病包括肾结石、尿道感染、膀胱控制问题和摄护腺问题。泌尿系统利用泌尿系统领域的雷射设备透过各种程序诊断和治疗这些疾病。例如,美国癌症协会的《2023 年癌症事实与数据》报告显示,2023 年美国将新增约 82,290 例膀胱癌病例,并有 16,710 例死于膀胱癌。此外,美国疾病管制与预防中心报告称,2021 年美国约有 24,710 例导管相关尿道感染病例。泌尿系统疾病发生率的上升是泌尿系统医疗雷射市场的主要驱动力。
产品创新是泌尿系统医疗雷射市场日益流行的关键趋势。产品创新有助于泌尿系统获得更佳疗效,提供诊断、治疗和微创手术,进而改善临床疗效、降低整体成本并提升患者的生活品质。例如,2022年11月,印度阿波罗医院推出了首台Moses 2.0雷射治疗仪,这是一项先进的雷射技术,用于无血无痛治疗高风险患者的大肾结石和前列腺肥大。 Moses 2.0雷射治疗仪采用内视镜操作,无需在皮肤上做切口。任何大小的肾结石和前列腺都可以完全治癒。
泌尿系统医疗雷射市场的主要企业正专注于开发先进技术产品,例如铥光纤雷射 (TFL) 系统,以实现卓越的精度、最大限度地减少组织损伤、提高结石破碎效率并提高安全性。铥光纤雷射 (TFL) 系统是一种高精度医疗雷射技术,主要用于泌尿系统的微创手术,例如肾结石破碎和前列腺组织切除,与传统雷射系统相比,具有更高的安全性和效率。例如,2023 年 2 月,中国泌尿系统雷射器製造商莱茵雷射科技推出了 UroFiber 150Q。这款 150W 超脉衝铥光纤雷射 (TFL) 系统采用创新的全光纤技术,专为最佳结石破碎和 BPH 摘除而设计。它采用客製化的高亮度、窄频谱、光纤耦合 792nm 二极体雷射来泵浦铥光纤,产生强大的 1940nm CW/QCW 雷射光束。在超脉衝模式(QCW)下,其最大雷射重复频率可达5000Hz,峰值功率可达600W,平均功率可达150W,最小脉衝能量可达0.025J。此外,在脉衝模式下,其脉衝能量在25Hz下可达6J;在连续模式(CW)下,其功率可达150W,可实现7天24小时高效运行,噪音水平低于60dB,完全符合业界标准。
2024年2月,美国医疗设备製造商OmniGuide Holdings (OGH) 将与UROTECH达成伙伴关係,以增强UROTECH的泌尿系统技术组合。此次合作将建立一个以RevoLix™ HTL(混合铥雷射疗法)为中心的全球网络,并与泌尿系统密切合作,特别专注于推进肾结石和良性前列腺增生 (BPH) 的治疗方法。 UROTECH是一家总部位于德国的医疗技术公司,专注于泌尿系统领域。
泌尿系统医疗雷射市场的主要公司包括Olympus Corporation、波士顿科学公司、科医人有限公司、理查德·沃尔夫有限公司、广达系统公司、史赛克公司、OmniGuide Holdings Inc.、Convergent Laser Technologies、Biolitec AG、Allengers Medical Systems Limited、常州美迪泰克贸易有限公司、苏州工业社科、医学. Ltd.、Anatomics、SignatureOrtho、Fresenius Medical Care AG &Co、KARL STORZ、EndoMed Systems GmbH、Dornier MedTech、Braun Melsungen AG、Lisa Laser、IRE-Polus、IPG Photonics Co、Capital Clinic Riga 和 Aertzio、IRE-Polus、IPG Photonics Co、Capital Clinic Riga 和 Aertzio、IRE-Polus、IPG Photonics Co、Capital Clinic Riga 及加拿大 Mertzio、IRE 医疗中心、莫斯科私人诊所、Clina Tambre、立体定位放射线手术中心「Sigulda」、Cook Medical、CR Bard、Healthtronics、Surgical Laser、Medtronic、AeroLase、Cutera、Synojar、 Medtronic、Sharplight Technologies、Syneron Medical、Solta Medical、Alma Laser、Euracare。
2024年泌尿系统医疗雷射市场最大的地区是北美。亚太地区是泌尿系统医疗雷射报告涵盖的第二大地区。泌尿系统医疗雷射器市场报告涵盖以下地区:亚太地区、西欧、东欧、北美、南美、中东和非洲。
泌尿系统医疗雷射市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、加拿大和西班牙。
泌尿系统医疗雷射市场涵盖钬雷射系统、二极体雷射系统、铥雷射系统等产品的销售。该市场的商品价值为出厂价,即商品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的商品价值。该市场的商品价值还包括商品製造商提供的任何相关服务。
Urology medical lasers are specialized instruments utilized in urology to conduct a range of minimally invasive surgeries and treatments targeting the urinary tract, bladder, kidneys, prostate, and other related organs. These lasers function by emitting concentrated beams of light energy to accurately cut, vaporize, or fragment tissue. The benefits of using these lasers include reduced bleeding, quicker recovery times, and minimal harm to surrounding tissues.
The urology medical lasers market encompasses various types, with notable examples being the holmium laser system, diode laser system, thulium laser system, and others. Holmium laser systems are specifically employed for the removal of stones in the bladder, kidneys, ureters, or urethra through laser-based procedures. The applications of these lasers extend to treating conditions such as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The primary end-users of urology medical lasers include hospitals, clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The urology medical lasers market research report is one of a series of new reports from The Business Research Company that provides urology medical lasers market statistics, including urology medical lasers industry global market size, regional shares, competitors with a urology medical lasers market share, detailed urology medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the urology medical lasers industry. This urology medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The urology medical lasers market size has grown steadily in recent years. It will grow from $1.03 billion in 2024 to $1.06 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to rapid technological advances, increased healthcare expenditure, rapid growth in elderly population, public health insurance reforms and strong economic growth in emerging markets.
The urology medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to an increase in mergers and acquisitions, an increase in R&D and innovations, and government initiatives will drive the growth. Major trends in the forecast period include emergence of novel technologies, use of big data and artificial intelligence, innovative laser treatments for benign prostatic hyperplasia, and use of fiber-optics in laser technology.
The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for thulium laser crystals and fiber-optic delivery systems, sourced from key regions such as Russia and Singapore, could lead to reduced availability of prostate treatment technologies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of urological disorders is a significant factor driving the demand for the urology medical lasers market. A rise in urological cases, including conditions such as bladder cancer and prostate diseases, is fostering the need for minimally invasive surgeries and associated devices. According to statistics from the American Institute for Cancer Research, bladder cancer ranks as the sixth most common cancer in men and the 17th most common cancer in women. This upsurge in urological diseases and conditions is fueling the demand for urological surgeries, thereby supporting the growth of the urology medical lasers market.
The continued growth in the incidence of urologic conditions is anticipated to propel the urology medical lasers market further. Urologic conditions encompass a range of issues affecting the reproductive or urinary tract systems in both males and females. Common urologic diseases include kidney stones, urinary tract infections, bladder control problems, and prostate issues. Urologists utilize laser instruments in the field of urology to diagnose and treat these conditions through various procedures. For instance, the American Cancer Society's Cancer Facts and Figures 2023 report reveals approximately 82,290 new cases of bladder cancer and 16,710 deaths from bladder cancer in the United States in 2023. Additionally, in 2021, the Centers for Disease Control and Prevention reported around 24,710 catheter-associated urinary tract infections in the U.S. The rising incidence of urologic conditions is a key driver for the urology medical lasers market.
Product innovation is a key trend gaining popularity in the urology medical lasers market. The product innovations assist urologists in achieving better outcomes and deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. For instance, in November 2022, Apollo, an India-based hospital launched first Moses 2.0, an advanced laser technology to treat large kidney stones and prostate enlargement on high-risk patients in a bloodless and painless manner. Procedures conducted with Moses 2.0 are endoscopic and do not involve cutting open of the skin. Any size of kidney stones and the prostate can be completely treated.
Leading companies in the urology medical lasers market are focusing on developing advanced technological products, such as thulium fiber laser (TFL) systems, to deliver superior precision, minimize tissue damage, enhance stone fragmentation efficiency, and improve safety. The thulium fiber laser (TFL) system represents a high-precision medical laser technology primarily employed in urology for minimally invasive procedures, including kidney stone fragmentation and prostate tissue removal, offering greater safety and efficiency compared to traditional laser systems. For example, in February 2023, Rhein Laser Technologies Ltd., a China-based manufacturer of urology lasers, launched the UroFiber 150Q. This 150W SuperPulsed thulium fiber laser (TFL) system features innovative all-fiber technology specifically designed for optimal stone lithotripsy and BPH enucleation. It employs a customized high-brightness narrow spectrum fiber-coupling 792nm diode laser to pump the thulium fiber, producing a powerful 1940nm CW&QCW laser. In SuperPulsed mode (QCW), it can achieve a peak power of 600W, with an average output of 150W and a maximum laser repetition rate of 5000Hz at a minimum pulse energy of 0.025J. Furthermore, it can reach up to 6J pulse energy at 25Hz in pulsed mode and maintain 150W in continuous mode (CW), operating efficiently 24/7 with noise levels below 60dB, fully compliant with industry standards.
In February 2024, OmniGuide Holdings (OGH), a US-based medical device company, entered into a partnership with UROTECH to enhance UROTECH's urology technology portfolio. This collaboration will work closely with urologists to establish a global network centered around RevoLix(TM) HTL (Hybrid Thulium Laser Therapy), focusing specifically on advancing treatments for kidney stones and benign prostatic hyperplasia (BPH). UROTECH is a Germany-based medical technology company specializing in urology.
Major companies operating in the urology medical lasers market include Olympus Corporation, Boston Scientific Corporation, Lumenis Ltd., Richard Wolf GmbH, Quanta System S.p.A., Stryker Corporation, OmniGuide Holdings Inc., Convergent Laser Technologies, Biolitec AG, Allengers Medical Systems Limited, Changzhou Meditech Trading Co. Ltd, Shuzhou Sunan Zimmered Medical Instrument Co. LTD, Narang Medical Limited, Atlas Surgical, Auxein Medical, Seikagaku Corporation, Anatomics, SignatureOrtho, Fresenius Medical Care AG & Co, KARL STORZ, EndoMed Systems GmbH, Dornier MedTech, Braun Melsungen AG, Lisa Laser, IRE-Polus, IPG Photonics Co, Capital Clinic Riga, Nick Mertziotis MDPh.D, Moscow Next Generation Clinic, Private Gurlife Hospital, Warsaw Surgery Clinic, Laser Med Medical Centre, Clinica Tambre, Stereotactic Radiosurgery Center 'SIGULDA', Cook Medical Incorporated, CR Bard, Healthtronics Inc, Surgical Lasers Inc, Medtronic, Aerolase, cutera, Cynosure inc, Sciton inc, Sharplight Technologies, Syneron Medical inc, SoltaMedical inc, Alma Lasers, Euracare.
North America was the largest region in the urology medical lasers market in 2024. Asia-Pacific was the second largest region in the urology medical lasers report. The regions covered in the urology medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the urology medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The urology medical lasers market consists of sales of holmium laser system, diode laser system, thulium laser system, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urology Medical Lasers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urology medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for urology medical lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urology medical lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.